Future Prospects of the Liquid Biopsy Market 2035
While the Liquid Biopsy Market holds immense clinical potential, several structural challenges must be addressed to achieve universal clinical adoption. One major technical hurdle involves detecting extremely low concentrations of circulating tumor DNA (ctDNA) in early-stage cancers, where normal background cell-free DNA significantly dilutes target signals. Biological noise, such as Clonal...
0 Comments 0 Shares 12 Views 0 Reviews